These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8458175)

  • 41. Sanofi Pharmaceuticals, Inc., et al.; withdrawal of approval of 21 new drug applications and 62 abbreviated new drug applications--FDA. Notice.
    Fed Regist; 1998 May; 63(91):26191-3. PubMed ID: 10179336
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accelerated approval of oncology products: a decade of experience.
    Dagher R; Johnson J; Williams G; Keegan P; Pazdur R
    J Natl Cancer Inst; 2004 Oct; 96(20):1500-9. PubMed ID: 15494600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FDA shortened drug approval time in 1995.
    Public Health Rep; 1996; 111(4):290. PubMed ID: 8711090
    [No Abstract]   [Full Text] [Related]  

  • 44. Regulations for in vivo radiopharmaceuticals used for diagnosis and monitoring. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 May; 64(94):26657-70. PubMed ID: 10558516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. From aspartame to Xenical. A look at the FDA review process.
    Trissler RJ
    J Am Diet Assoc; 1999 Jul; 99(7):797-8. PubMed ID: 10405675
    [No Abstract]   [Full Text] [Related]  

  • 46. Draft guidance for industry; exports and imports under the FDA Export Reform and Enhancement Act of 1996--FDA. Notice.
    Fed Regist; 1998 Jun; 63(113):32219-34. PubMed ID: 10180275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Removal of regulations regarding certification of drugs composed wholly or partly of insulin; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 May; 63(92):26690-3. PubMed ID: 10179340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug development process for a product with a primary pediatric indication.
    Allen AJ; Michelson D
    J Clin Psychiatry; 2002; 63 Suppl 12():44-9. PubMed ID: 12562061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Applications for Food and Drug Administration application approval to market a new drug; revision of postmarketing reporting requirements. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Oct; 72(201):58993-9000. PubMed ID: 17966558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Supplemental applications proposing labeling changes for approved drugs, biologics, and medical devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Aug; 73(164):49603-10. PubMed ID: 18958946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FDA notifications. FDA: tentative approval of generic nevirapine.
    AIDS Alert; 2008 Jul; 23(7):80-1. PubMed ID: 18693339
    [No Abstract]   [Full Text] [Related]  

  • 52. New drugs for human use; clarification of requirements for patent holder notification--FDA. Proposed rule.
    Fed Regist; 1998 Mar; 63(44):11174-7. PubMed ID: 10177511
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FDA notifications. FDA grants tentative approval to generic stavudine.
    AIDS Alert; 2006 Feb; 21(2):24. PubMed ID: 16562341
    [No Abstract]   [Full Text] [Related]  

  • 54. FDA notifications. FDA grants tentative approval to generic Nevirapine.
    AIDS Alert; 2006 Feb; 21(2):23-4. PubMed ID: 16562340
    [No Abstract]   [Full Text] [Related]  

  • 55. United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy.
    Kane RC; Farrell AT; Sridhara R; Pazdur R
    Clin Cancer Res; 2006 May; 12(10):2955-60. PubMed ID: 16707588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sailing the straits of approval: the nature of FDA approval and its implications for surgeons.
    Reiter D
    Facial Plast Surg Clin North Am; 2007 May; 15(2):247-50, vii-viii. PubMed ID: 17544941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sweeping changes to Food and Drug Administration and drug safety regulations.
    Cross JT
    Arch Intern Med; 2007 Apr; 167(7):732. PubMed ID: 17420439
    [No Abstract]   [Full Text] [Related]  

  • 58. Import for export; reporting and recordkeeping requirements for unapproved or violative products imported for further processing or incorporation and subsequent export--FDA. Proposed rule.
    Fed Regist; 1998 Nov; 63(226):64930-7. PubMed ID: 10338872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delavirdine gets FDA approval. Food and Drug Administration.
    AIDS Alert; 1997 Jun; 12(6):70. PubMed ID: 11364363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Removal of regulations regarding certification of drugs composed wholly or partly of insulin--FDA. Direct final rule.
    Fed Regist; 1998 May; 63(92):26694-9. PubMed ID: 10179341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.